The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds

European Journal of Pharmacology

Volumn 388, Issue 1, 2000, Pages 57-67

  Prinssen, Eric P M ^a   Koek, Wouter ^a   Kleven, Mark S ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

5 HT (5 hydroxytryptamine); 5 HT(2C) receptor; Antipsychotic; Behavior; Food intake; Hypolocomotion; Hypophagia; Locomotor activity; mCPP (3 chlorophenyl)piperazine; Neuroleptic; serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 2,3,3A,12B TETRAHYDRO 3 METHYL 1H DIBENZO[B,F]OXEPINO[10,11 C]PYRROLE; CLOZAPINE; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PIPAMPERONE; PRAZOSIN; RISPERIDONE; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; FOOD INTAKE; HYPOPHAGIA; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; MALE; MOTOR ACTIVITY; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0033984692     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00859-6     Document Type: Article

References (46)

1. Aulakh C.S., Zohar J., Wozniak K.M., Hill J.L., Murphy D.L. Long-term lithium treatment in rats attenuates m-chlorophenylpiperazine-induced decreases in food intake but not locomotor activity. Psychopharmacology. 98:1989;448-452.
2. Baumann M.H., Rutter J.J., Auerbach S.B. Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats. Neuropharmacology. 32:1993;1381-1386.
3. 2B) in rat stomach fundus longitudinal muscle. Br. J. Pharmacol. 112:1994;323-331.
4. 1C receptors in drug-induced penile erections in rats. Psychopharmacology. 101:1990;57-61.
5. 2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study. Psychopharmacology. 143:1999;89-96.
6. Broekkamp C.L., De Graaf J.S., van Delft A.M. Behavioural pharmacology of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino-[4,5-c] pyrrolidine maleate, a compound interacting with dopaminergic and serotonergic receptors. Arzneim.-Forsch./Drug Res. 40:1990;544-549.
7. 2C receptor antagonist. J. Med. Chem. 40:1997;3494-3496.
8. 1C sites. Eur. J. Pharmacol. 191:1990;93-96.
9. 2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics. Neurosci. Lett. 181:1994;65-68.
10. Conn P.J., Sanders-Bush E. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT2 and 5-HT-1c) receptors. J. Pharmacol. Exp. Ther. 242:1987;552-557.
11. Curzon G. Serotonin and eating disorders: pharmacological relationship. Langer S.Z., Brunello N., Racagni G., Mendlewicz J. Serotonin Receptor Subtypes: Pharmacological Significance and Clinical Implications. 1992;112-128 Karger, Basel.
12. Czyrak A., Skuza G., Rogoz Z., Frankiewicz T., Maj J. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes. Arzneim.-Forsch./Drug Res. 44:1994;113-118.
13. Eriksson E., Engberg G., Bing O., Nissbrandt H. Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain. Neuropsychopharmacology. 20:1999;287-296.
14. Fiorella D., Rabin R.A., Winter J.C. The interaction of clozapine with the metachlorophenylpiperazine (mCPP) discriminative stimulus. Life Sci. 58:1996;PL353-PL358.
15. 2B receptor antagonist with improved affinity, selectivity, and oral activity. J. Med. Chem. 38:1995;2524-2530.
16. 1C receptor antagonist. J. Med. Chem. 36:1993;1104-1107.
17. 2C receptor mode of action. Psychopharmacology. 137:1998;292-302.
18. Hubert J.J. Bioassay. 1984;Kendall/Hunt, Dubuque.
19. Hutson P.H., Donohoe T.P., Curzon G. Infusion of the 5-hydroxytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology. 95:1988;550-552.
20. 1C receptors and their therapeutic relevance. Curr. Opin. Invest. Drugs. 2:1993;317-362.
21. 2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology. 36:1997;233-239.
22. 1B receptors. Psychopharmacology. 96:1988;93-100.
23. 1C receptors. Br. J. Pharmacol. 94:1988;137-147.
24. 1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia. Br. J. Pharmacol. 103:1991;2016-2020.
25. 2B receptor antagonist with anxiolytic-like properties. Br. J. Pharmacol. 117:1996;427-434.
26. 2C receptor antagonist. Neuropharmacology. 36:1997;609-620.
27. 2C/2B receptor antagonist. Br. J. Pharmacol. 111:1994;797-802.
28. Klodzinska A., Jaros T., Chojnacka-Wojcik E., Maj J. Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP). J. Neural Transm.: Parkinson's Dis. Dementia Sect. 1:1989;207-218.
29. 1C receptors. Neurosci. Biobehav. Rev. 16:1992;95-105.
30. 2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs. Neuropsychopharmacology. 13:1995;139-150.
31. 2 receptors. Psychopharmacology. 112:1993;S40-S54. Suppl.
32. Lucki I., Ward H.R., Frazer A. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. J. Pharmacol. Exp. Ther. 249:1989;155-164.
33. 1B receptors? J. Neural Transm. 73:1988;43-55.
34. 2A receptor affinity. J. Med. Chem. 38:1995;28-33.
35. Prinssen E.P.M., Kleven M.S., Vignon J., Kamenka J.M., Koek W. Effects of repeated administration of N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine and cocaine on locomotor activity in C57BL/6 mice. J. Pharmacol. Exp. Ther. 276:1996;904-911.
36. 1A receptor involvement in yawning and penile erections induced by apomorphine, physostigmine and mCPP in rats. Psychopharmacology. 120:1995;376-383.
37. 2C receptor antagonist. Br. J. Pharmacol. 126:1999;572-574.
38. Robertson D.W., Bloomquist W., Wong D.T., Cohen M.L. mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors. Life Sci. 50:1992;599-605.
39. 1C receptors. J. Pharmacol. Exp. Ther. 260:1992;1361-1365.
40. Salamone J.D., Zigmond M.J., Stricker E.M. Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions. Neuroscience. 39:1990;17-24.
41. Schneider L.H., Gibbs J., Smith G.P. D-2 selective receptor antagonists suppress sucrose sham feeding in the rat. Brain Res. Bull. 17:1986;605-611.
42. Schotte A., Janssen P.F.M., Gommeren W., Luyten W.H.M.L., Van Gompel P., Lesage A.S., De Loore K., Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology. 124:1996;57-73.
43. Tallarida R.J., Murray R.G. Manual of pharmacological calculations with computer programs. 1987;Springer-Verlag, New York.
44. 2C serotonin receptors. Nature. 374:1995;542-546.
45. Waters N., Löfberg L., Haadsma-Svensson S., Svensson K., Sonesson C., Carlsson A. Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour. J. Neural Transm. 98:1994;39-55.
46. Wonnacott T.H., Wonnacott R.J. Introductory Statistics. 1990;Wiley, New York.